France Christophe Cizeron, president of Lyonbiopole, discusses the important economic and industrial position of the research cluster in the Rhone-Alps Region as well as the challenges posed by domestic and international competition. Between 2007-2016, the number of biotech companies doubled in the Lyon region and there was a sharp increase…
Switzerland Nasri Nahas, CEO of Biopôle in Switzerland, discusses his motivations for joining the biotech, and his mission to re-position the organization as a life sciences ecosystem bringing together academia, business, and research. What motivated you to join Biopôle in October 2015? I began my career as a molecular biologist in France…
Pharma Lyonbiopole was established in 2005 as a cluster designed to support the local business community focused on infectious diseases and microbiology. Philippe Archinard, the Biopole’s president, traces the evolution of the cluster over the last decade while underscoring the critical importance of transparency and collaboration between government, industry and academia.…
Lyonbiopôle As a majority of our readers are American that may be used to a different model of clusters can you explain the unique characteristics of the pôles de compétitivité? The biggest differentiating point is that the clusters have been founded on government initiative to create competitive zones across multiple industries.…
See our Cookie Privacy Policy Here
